Corium looks to go public for up to $50M; Researchers develop milk duct delivery method for breast cancer drugs;

> Transdermal delivery specialist Corium International filed with the Securities and Exchange Commission for an IPO expected to bring in about $50 million. Release

> A new delivery system developed at South Dakota State University is designed to deliver drugs through the milk ducts to reduce side effects and apply larger doses to affected tissue. More

> Sensile Medical completed a study for its semi-disposable patch pump for subcutaneous furosemide therapy. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.